drugset / Trial / NCT01989689
Etanercept and Vascular Function in Psoriasis
RandomizedCrossoverTriple-blindTreatment
Summary
The investigators plan to measure the health of the vascular system of subjects taking Etanercept for the treatment of plaque psoriasis.
Timeline
- Start
- 2010-08
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 50 mg | Subcutaneous |